InsightRX Raising Growth Capital From CIBC Innovation Banking
By Amit Chowdhry ● Feb 26, 2024
CIBC Innovation Banking recently announced that it has provided growth financing to InsightRX, a San Francisco-based software company utilizing quantitative pharmacology and artificial intelligence (AI) to improve therapeutic decision-making from phase I drug development to the point of patient care. And InsightRX applies patient-specific data and quantitative models to tailor dosing for complex treatments, including antibiotics, chemotherapeutic agents, and immunosuppressants. InsightRX also taps into AI to empower data scientists to analyze clinical trial data, aid in trial design, understand dose-exposure-response relationships, and refine dosing strategies for regulatory submissions.